Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remo Guerrini

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Behavioural Brain Research|March 12, 2014
Neuropeptide S counteracts 6-OHDA-induced motor deficits in miceJulia J Didonet, Judney C Cavalcante, Lisiane de S Souza, et al.
Journal of Medicinal Chemistry|March 4, 2005
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligandsRemo Guerrini, Girolamo Caló, David G Lambert, et al.
The Journal of Biological Chemistry|May 25, 2006
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activationAdelheid L Roth, Erika Marzola, Anna Rizzi, et al.
European Journal of Pharmacology|July 22, 2019
Dopamine D<sub>1</sub> and D<sub>2</sub> receptors mediate neuropeptide S-induced antinociception in the mouse formalin testVictor A D Holanda, Matheus C Oliveira, Lisiane S Souza, et al.
Peptides|February 23, 2010
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68Chiara Ruzza, Anna Rizzi, Claudio Trapella, et al.
Molecular and Cellular Endocrinology|December 7, 2021
Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell lineSilvia Limoncella, Clara Lazzaretti, Elia Paradiso, et al.
Plos One|June 9, 2016
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)Mark F Bird, Maria Camilla Cerlesi, Mark Brown, et al.
Journal of Medicinal Chemistry|March 27, 2023
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of CancerValentina Albanese, Sonia Missiroli, Mariasole Perrone, et al.
Frontiers in Pharmacology|November 29, 2024
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulationGaetano Marverti, Maria Gaetana Moschella, Alice Belardo, et al.
Nature|May 19, 2012
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimeticAaron A Thompson, Wei Liu, Eugene Chun, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Behavioural Brain Research|March 12, 2014
Neuropeptide S counteracts 6-OHDA-induced motor deficits in miceJulia J Didonet, Judney C Cavalcante, Lisiane de S Souza, et al.
Journal of Medicinal Chemistry|March 4, 2005
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligandsRemo Guerrini, Girolamo Caló, David G Lambert, et al.
The Journal of Biological Chemistry|May 25, 2006
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activationAdelheid L Roth, Erika Marzola, Anna Rizzi, et al.
European Journal of Pharmacology|July 22, 2019
Dopamine D<sub>1</sub> and D<sub>2</sub> receptors mediate neuropeptide S-induced antinociception in the mouse formalin testVictor A D Holanda, Matheus C Oliveira, Lisiane S Souza, et al.
Peptides|February 23, 2010
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68Chiara Ruzza, Anna Rizzi, Claudio Trapella, et al.
Molecular and Cellular Endocrinology|December 7, 2021
Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell lineSilvia Limoncella, Clara Lazzaretti, Elia Paradiso, et al.
Plos One|June 9, 2016
Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)Mark F Bird, Maria Camilla Cerlesi, Mark Brown, et al.
Journal of Medicinal Chemistry|March 27, 2023
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of CancerValentina Albanese, Sonia Missiroli, Mariasole Perrone, et al.
Frontiers in Pharmacology|November 29, 2024
Enhanced anticancer effect of thymidylate synthase dimer disrupters by promoting intracellular accumulationGaetano Marverti, Maria Gaetana Moschella, Alice Belardo, et al.
Nature|May 19, 2012
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimeticAaron A Thompson, Wei Liu, Eugene Chun, et al.
Pageof 22